Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis.
作者信息
Schiavone Marco, Boriani Giuseppe, Di Biase Luigi
机构信息
Department of Clinical Electrophysiology and Cardiac Pacing, Centro Cardiologico Monzino, IRCCS, Milan, Italy.
Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena, Modena, Italy.
出版信息
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf102.
Abstract
摘要
相似文献
1
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis.虽僵硬但仍保持节律：心脏淀粉样变性和结节病中房颤的导管消融治疗
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf102.
2
Catheter ablation of atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis: procedural findings and outcomes.心脏淀粉样变性和结节病患者心房颤动的导管消融：手术结果和预后
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf100.
3
Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.非阵发性心房颤动患者消融治疗的疗效与安全性
Cochrane Database Syst Rev. 2016 Nov 22;11(11):CD012088. doi: 10.1002/14651858.CD012088.pub2.
4
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术：系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
5
Surgical or interventional treatment for adult patients with atrial septal defect and atrial fibrillation: A systemic review and meta-analysis.成人房间隔缺损合并心房颤动患者的手术或介入治疗：一项系统评价和荟萃分析。
Asian J Surg. 2022 Jan;45(1):62-67. doi: 10.1016/j.asjsur.2021.06.021. Epub 2021 Jul 1.
6
The techniques for catheter ablation of paroxysmal and persistent atrial fibrillation: a systematic review.阵发性和持续性心房颤动导管消融技术：系统评价。
Curr Opin Cardiol. 2011 Jan;26(1):17-24. doi: 10.1097/HCO.0b013e3283413925.
7
Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction.左心室收缩功能障碍患者与无左心室收缩功能障碍患者行导管消融治疗心房颤动的有效性和安全性的荟萃分析。
Am J Cardiol. 2010 Nov 1;106(9):1284-91. doi: 10.1016/j.amjcard.2010.06.053.
8
Optimal timing for atrial fibrillation patients to undergo catheter ablation.心房颤动患者进行导管消融的最佳时机。
Commun Med (Lond). 2025 Jun 22;5(1):245. doi: 10.1038/s43856-025-00960-1.
9
Remodeling and Reverse-Remodeling of Left Atrium and Appendage After Catheter Ablation for Atrial Fibrillation.房颤导管消融术后左心房及心耳的重塑与逆向重塑
Am J Cardiol. 2025 Jun 7;253:23-31. doi: 10.1016/j.amjcard.2025.06.001.
10
The Need for Consistent Predictors of Success for Surgical Ablation of Atrial Fibrillation: A Call to Action.心房颤动外科消融成功的一致性预测指标的必要性：行动呼吁。
Innovations (Phila). 2017 Nov/Dec;12(6):421-429. doi: 10.1097/IMI.0000000000000426.
本文引用的文献
1
Catheter ablation of atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis: procedural findings and outcomes.心脏淀粉样变性和结节病患者心房颤动的导管消融：手术结果和预后
Europace. 2025 Jun 3;27(6). doi: 10.1093/europace/euaf100.
2
Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).心房心肌病再探——概念的演变：欧洲心脏病学会心律协会 (EHRA)、心律学会 (HRS)、亚太心律学会 (APHRS) 和拉丁美洲心律学会 (LAHRS) 的临床共识声明。
Europace. 2024 Aug 30;26(9). doi: 10.1093/europace/euae204.
3
Clinical outcomes of catheter ablation for atrial fibrillation, atrial flutter, and atrial tachycardia in wild-type transthyretin amyloid cardiomyopathy: a proposed treatment strategy for catheter ablation in each arrhythmia.野生型转甲状腺素蛋白淀粉样变心肌病中心房颤动、心房扑动和房性心动过速的导管消融的临床转归：每种心律失常导管消融的治疗策略建议。
Europace. 2024 Jun 3;26(6). doi: 10.1093/europace/euae155.
4
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.2024 年欧洲心律协会/心律学会/亚太心律协会/拉丁美洲心律协会专家共识声明：导管和手术消融治疗心房颤动。
Heart Rhythm. 2024 Sep;21(9):e31-e149. doi: 10.1016/j.hrthm.2024.03.017. Epub 2024 Apr 8.
5
Prognostic Utility of Left Atrial Strain to Predict Thrombotic Events and Mortality in Amyloid Cardiomyopathy.左心房应变预测淀粉样心肌病血栓事件和死亡的预后价值。
JACC Cardiovasc Imaging. 2023 Nov;16(11):1371-1383. doi: 10.1016/j.jcmg.2023.01.015. Epub 2023 Apr 12.
6
Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study.心脏结节病中心律失常的发生率及预测因素：一项多模态影像学研究。
JACC Cardiovasc Imaging. 2022 Sep;15(9):1622-1631. doi: 10.1016/j.jcmg.2022.02.025. Epub 2022 May 11.
7
Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial.MRI 引导下纤维消融与常规导管消融对持续性心房颤动患者心房颤动复发的影响：DECAAF II 随机临床试验。
JAMA. 2022 Jun 21;327(23):2296-2305. doi: 10.1001/jama.2022.8831.
8
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.转甲状腺素蛋白心脏淀粉样变相关性心房颤动：节律控制策略的预测因素、发生率和疗效。
JACC Clin Electrophysiol. 2020 Sep;6(9):1118-1127. doi: 10.1016/j.jacep.2020.04.019. Epub 2020 Jul 29.
9
Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics.针对具有选择性激活特征的低电压区域进行持续性心房颤动消融。
Circ Arrhythm Electrophysiol. 2016 Mar;9(3). doi: 10.1161/CIRCEP.115.002962.
10
Early Detection of Bi-ventricular and Atrial Mechanical Dysfunction Using Two-Dimensional Speckle Tracking Echocardiography in Patients with Sarcoidosis.二维斑点追踪超声心动图在结节病患者中早期检测双心室及心房机械功能障碍
Lung. 2015 Oct;193(5):669-75. doi: 10.1007/s00408-015-9748-0. Epub 2015 May 20.
Zotero 插件